2009 news archive
26 November, 2009
» ELARA Pharmaceuticals
receives EUR 4.6 Million funding and names Dr. Christof Antz as
Chief Business Officer.
Financing supports development of lead candidate for the treatment
of Multiple Myeloma and other cancers to IND.
» ELARA Pharmaceuticals
erhält Finanzierung in Höhe von 4,6 Millionen Euro und
ernennt Dr. Christof Antz zum Chief Business Officer
Finanzmittel ermöglichen die Entwicklung eines innovativen
Medikamentenkandidaten zur Behandlung des Multiplen Myeloms und
anderer Krebserkrankungen bis zur Klinik.
»
Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery
Collaboration to a New Level.....08.2009
• Elara Pharmaceuticals Presents at 2009 BIO International
Convention
Heidelberg, May 14, 2009
CEO Joe Lewis presented at the 2009 BIO International Convention
at the Georgia International Convention Center in Atlanta, Georgia,
May 20th at 10:20 AM in Room 311 of Building A, Level 3
• Elara Pharmaceuticals Presents at BIO Equity Europe,
Heidelberg, May 14, 2009
CEO Joe Lewis presented at the 2009 BIO Equity Europe at the
Hilton Munich Park Hotel, Munich, Germany, June 9th at 17:10 AM
in Ballroom 2
2007/8 news archive
•
CHE Manager; ELARA_Spitzencluster
• Mannheimer
Morgen
2006 news archive
•
Förderung: Aus dem Labor in die Wirtschaft: GO-Bio macht
Biowissenschaftler zu Unternehmern
• EMBL /ELARA
joint press release, 09 August, 2006
•
Bionity.com: EMBL scientists found start-up company Elara Pharmaceuticals
to develop anti-cancer drug
•
Start-up Elara formed to develop anticancer drugs
•
Elara Pharmaceuticals GmbH provides a fast track from bench to
clinical application
•
Eurekalert, 09.08.2006